BlackRock’s IGC Pharma IGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$185K Hold
703,798
﹤0.01% 4790
2025
Q4
$198K Hold
703,798
﹤0.01% 4727
2025
Q3
$293K Hold
703,798
﹤0.01% 4598
2025
Q2
$215K Hold
703,798
﹤0.01% 4656
2025
Q1
$201K Hold
703,798
﹤0.01% 4600
2024
Q4
$236K Hold
703,798
﹤0.01% 4588
2024
Q3
$300K Hold
703,798
﹤0.01% 4442
2024
Q2
$305K Sell
703,798
-11,642
-2% -$5.79K ﹤0.01% 4455
2024
Q1
$286K Sell
715,440
-2,444
-0.3% -$759 ﹤0.01% 4516
2023
Q4
$201K Hold
717,884
﹤0.01% 4634
2023
Q3
$258K Sell
717,884
-37,902
-5% -$13.6K ﹤0.01% 4612
2023
Q2
$236K Sell
755,786
-76
-0% -$25 ﹤0.01% 4691
2023
Q1
$257K Hold
755,862
﹤0.01% 4708
2022
Q4
$240K Buy
755,862
+11,642
+2% +$4.75K ﹤0.01% 4800
2022
Q3
$321K Buy
744,220
+56
+0% +$30 ﹤0.01% 4848
2022
Q2
$394K Sell
744,164
-114,622
-13% -$72.3K ﹤0.01% 4849
2022
Q1
$815K Sell
858,786
-2,428
-0.3% -$2.36K ﹤0.01% 4733
2021
Q4
$842K Buy
861,214
+18,931
+2% +$25.4K ﹤0.01% 4723
2021
Q3
$1.25M Sell
842,283
-972
-0.1% -$1.57K ﹤0.01% 4500
2021
Q2
$1.38M Sell
843,255
-67,711
-7% -$103K ﹤0.01% 4418
2021
Q1
$1.63M Buy
910,966
+1,744
+0.2% +$3.17K ﹤0.01% 4356
2020
Q4
$1.42M Buy
909,222
+881,396
+3,168% +$1.3M ﹤0.01% 4131
2020
Q3
$29K Buy
27,826
+12
+0% +$12 ﹤0.01% 4668
2020
Q2
$17K Sell
27,814
-66,730
-71% -$36.2K ﹤0.01% 4722
2020
Q1
$47K Buy
94,544
+60,290
+176% +$33.4K ﹤0.01% 4485
2019
Q4
$22K Buy
34,254
+26,774
+358% +$21.9K ﹤0.01% 4642
2019
Q3
$7K Buy
+7,480
New +$9K ﹤0.01% 4750

Other funds holding IGC